Pfizer to expand venture investing with $600M commitment

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (NYSE:PFE) plans to invest $600M in biotechnology and other emerging growth companies through Pfizer Ventures. Pfizer Ventures will seek to invest ~25% of its available capital ($150M) in promising early-stage neuroscience companies.

Beyond neuroscience, Pfizer Ventures will continue to invest across a broad range of therapeutic areas of interest such as oncology, inflammation and immunology, rare disease, internal medicine and vaccines.

Shares are up a fraction premarket.

Subscribe for full text news in your inbox